CNAM
Campbell Newman Asset Management’s Corcept Therapeutics CORT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.6M | Buy |
35,360
+2,375
| +7% | +$174K | 0.21% | 57 |
|
|
2025
Q1 | $3.77M | Sell |
32,985
-16,142
| -33% | -$1.84M | 0.32% | 40 |
|
|
2024
Q4 | $2.48M | Sell |
49,127
-247
| -0.5% | -$12.4K | 0.2% | 52 |
|
|
2024
Q3 | $2.29M | Sell |
49,374
-809
| -2% | -$37.4K | 0.17% | 57 |
|
|
2024
Q2 | $1.63M | Sell |
50,183
-85
| -0.2% | -$2.76K | 0.13% | 70 |
|
|
2024
Q1 | $1.27M | Buy |
50,268
+1,181
| +2% | +$29.7K | 0.1% | 85 |
|
|
2023
Q4 | $1.59M | Buy |
49,087
+211
| +0.4% | +$6.85K | 0.14% | 69 |
|
|
2023
Q3 | $1.33M | Sell |
48,876
-861
| -2% | -$23.5K | 0.13% | 75 |
|
|
2023
Q2 | $1.11M | Buy |
49,737
+1,092
| +2% | +$24.3K | 0.1% | 83 |
|
|
2023
Q1 | $1.05M | Buy |
48,645
+459
| +1% | +$9.94K | 0.1% | 84 |
|
|
2022
Q4 | $979K | Buy |
48,186
+1,528
| +3% | +$31K | 0.1% | 83 |
|
|
2022
Q3 | $1.2M | Buy |
46,658
+1,116
| +2% | +$28.6K | 0.13% | 72 |
|
|
2022
Q2 | $1.08M | Buy |
45,542
+1,974
| +5% | +$46.9K | 0.11% | 72 |
|
|
2022
Q1 | $981K | Buy |
43,568
+846
| +2% | +$19K | 0.09% | 90 |
|
|
2021
Q4 | $846K | Buy |
42,722
+1,126
| +3% | +$22.3K | 0.08% | 95 |
|
|
2021
Q3 | $819K | Buy |
41,596
+2,177
| +6% | +$42.9K | 0.08% | 97 |
|
|
2021
Q2 | $867K | Buy |
39,419
+2,012
| +5% | +$44.3K | 0.09% | 94 |
|
|
2021
Q1 | $890K | Buy |
37,407
+1,770
| +5% | +$42.1K | 0.09% | 95 |
|
|
2020
Q4 | $932K | Buy |
35,637
+2,682
| +8% | +$70.1K | 0.11% | 85 |
|
|
2020
Q3 | $574K | Buy |
32,955
+611
| +2% | +$10.6K | 0.07% | 98 |
|
|
2020
Q2 | $544K | Buy |
32,344
+304
| +0.9% | +$5.11K | 0.07% | 95 |
|
|
2020
Q1 | $381K | Sell |
32,040
-1,540
| -5% | -$18.3K | 0.07% | 99 |
|
|
2019
Q4 | $406K | Sell |
33,580
-53
| -0.2% | -$641 | 0.05% | 112 |
|
|
2019
Q3 | $475K | Sell |
33,633
-271
| -0.8% | -$3.83K | 0.07% | 108 |
|
|
2019
Q2 | $378K | Buy |
33,904
+2,267
| +7% | +$25.3K | 0.06% | 114 |
|
|
2019
Q1 | $371K | Buy |
31,637
+815
| +3% | +$9.56K | 0.06% | 117 |
|
|
2018
Q4 | $412K | Buy |
30,822
+3,248
| +12% | +$43.4K | 0.07% | 106 |
|
|
2018
Q3 | $387K | Buy |
+27,574
| New | +$387K | 0.06% | 117 |
|